Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
Marco H Ji,1 Natalia F Callaway,1 Margaret A Greven,2 Daniel Vail,1 Darius M Moshfeghi1 1Byers Eye Institute, Horngren Family Vitreoretinal Center, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California; 2Department of Ophthalmology, Wake Forest University School...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c80a5fc3eb0e413aa81e8dab410cd517 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c80a5fc3eb0e413aa81e8dab410cd517 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c80a5fc3eb0e413aa81e8dab410cd5172021-12-02T10:02:41ZTelemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort1177-5483https://doaj.org/article/c80a5fc3eb0e413aa81e8dab410cd5172020-04-01T00:00:00Zhttps://www.dovepress.com/telemedicine-follow-up-for-intravitreal-bevacizumab-injection-in-the-s-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Marco H Ji,1 Natalia F Callaway,1 Margaret A Greven,2 Daniel Vail,1 Darius M Moshfeghi1 1Byers Eye Institute, Horngren Family Vitreoretinal Center, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California; 2Department of Ophthalmology, Wake Forest University School of Medicine, Winston-Salem, North CarolinaCorrespondence: Darius M Moshfeghi Tel +1 (650) 723-6995Email dariusm@stanford.eduAbstract: Telemedicine has emerged as a potential solution to face the disproportion between infants that need to be screened for retinopathy of prematurity (ROP) and the lack of ophthalmologists. We evaluated its utility in the follow-up after off-label intravitreal injection of bevacizumab. None of the treated infants ended up with bad anatomic outcome. Telemedicine is an alternative safe method to monitor patients after treatment.Keywords: pediatric retina, retina, pediatric ophthalmologyJi MHCallaway NFGreven MAVail DMoshfeghi DMDove Medical Pressarticlepediatric retinaretinapediatric ophthalmologyOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 14, Pp 1161-1163 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
pediatric retina retina pediatric ophthalmology Ophthalmology RE1-994 |
spellingShingle |
pediatric retina retina pediatric ophthalmology Ophthalmology RE1-994 Ji MH Callaway NF Greven MA Vail D Moshfeghi DM Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort |
description |
Marco H Ji,1 Natalia F Callaway,1 Margaret A Greven,2 Daniel Vail,1 Darius M Moshfeghi1 1Byers Eye Institute, Horngren Family Vitreoretinal Center, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California; 2Department of Ophthalmology, Wake Forest University School of Medicine, Winston-Salem, North CarolinaCorrespondence: Darius M Moshfeghi Tel +1 (650) 723-6995Email dariusm@stanford.eduAbstract: Telemedicine has emerged as a potential solution to face the disproportion between infants that need to be screened for retinopathy of prematurity (ROP) and the lack of ophthalmologists. We evaluated its utility in the follow-up after off-label intravitreal injection of bevacizumab. None of the treated infants ended up with bad anatomic outcome. Telemedicine is an alternative safe method to monitor patients after treatment.Keywords: pediatric retina, retina, pediatric ophthalmology |
format |
article |
author |
Ji MH Callaway NF Greven MA Vail D Moshfeghi DM |
author_facet |
Ji MH Callaway NF Greven MA Vail D Moshfeghi DM |
author_sort |
Ji MH |
title |
Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort |
title_short |
Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort |
title_full |
Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort |
title_fullStr |
Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort |
title_full_unstemmed |
Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort |
title_sort |
telemedicine follow-up for intravitreal bevacizumab injection in the stanford university network for diagnosis of retinopathy of prematurity (sundrop) cohort |
publisher |
Dove Medical Press |
publishDate |
2020 |
url |
https://doaj.org/article/c80a5fc3eb0e413aa81e8dab410cd517 |
work_keys_str_mv |
AT jimh telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort AT callawaynf telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort AT grevenma telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort AT vaild telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort AT moshfeghidm telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort |
_version_ |
1718397712375742464 |